These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8818648)
41. Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer. Philip R; Clary B; Brunette E; Kilinski L; Murugesh D; Sorich M; Yau J; Lebkowski J; Lyerly HK; Philip M Clin Cancer Res; 1996 Jan; 2(1):59-68. PubMed ID: 9816091 [TBL] [Abstract][Full Text] [Related]
42. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism. Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012 [TBL] [Abstract][Full Text] [Related]
43. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene. Cao X; Wang Q; Ju DW; Tao Q; Wang J J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706 [TBL] [Abstract][Full Text] [Related]
44. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394 [TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607 [TBL] [Abstract][Full Text] [Related]
46. Combined liposome-mediated cytosine deaminase gene therapy with radiation in killing rectal cancer cells and xenografts in athymic mice. Li S; Yu B; An P; Chen G; Lu W; Cai H; Guo W; Zuo F Clin Cancer Res; 2005 May; 11(9):3574-8. PubMed ID: 15867262 [TBL] [Abstract][Full Text] [Related]
47. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence. Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497 [TBL] [Abstract][Full Text] [Related]
48. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts. Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018 [TBL] [Abstract][Full Text] [Related]
49. Factors influencing the drug sensitization of human tumor cells for in situ lipofection. Son K; Huang L Gene Ther; 1996 Jul; 3(7):630-4. PubMed ID: 8818651 [TBL] [Abstract][Full Text] [Related]
50. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome]. Wang KM; Xia AD; Chen SS Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639 [TBL] [Abstract][Full Text] [Related]
51. Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice. Egilmez NK; Hess SD; Chen FA; Takita H; Conway TF; Bankert RB Cancer Res; 2002 May; 62(9):2611-7. PubMed ID: 11980657 [TBL] [Abstract][Full Text] [Related]
52. Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice. Charoensit P; Kawakami S; Higuchi Y; Yamashita F; Hashida M Cancer Gene Ther; 2010 Jul; 17(7):512-22. PubMed ID: 20414324 [TBL] [Abstract][Full Text] [Related]
53. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043 [TBL] [Abstract][Full Text] [Related]
54. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317 [TBL] [Abstract][Full Text] [Related]
55. Cationic liposomes with plasmid DNA influence cancer metastatic capability. Ota T; Maeda M; Tatsuka M Anticancer Res; 2002; 22(6C):4049-52. PubMed ID: 12553031 [TBL] [Abstract][Full Text] [Related]
56. Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model. Lee MJ; Cho SS; You JR; Lee Y; Kang BD; Choi JS; Park JW; Suh YL; Kim JA; Kim DK; Park JS Gene Ther; 2002 Jul; 9(13):859-66. PubMed ID: 12080380 [TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy. Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695 [TBL] [Abstract][Full Text] [Related]
59. Direct transfer of IL-12 gene into growing Renca tumors. Budryk M; WilczyĆska U; Szary J; Szala S Acta Biochim Pol; 2000; 47(2):385-91. PubMed ID: 11051203 [TBL] [Abstract][Full Text] [Related]
60. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity. Milas M; Yu D; Lang A; Ge T; Feig B; El-Naggar AK; Pollock RE Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]